In Vitro Evaluations and In Vivo Toxicity and Efficacy Studies of MFM501 against MRSA

Second-Generation Phenylthiazole Antibiotics with Enhanced Pharmacokinetic Properties

(2016) Mohammed A. Seleem et al.   JOURNAL OF MEDICINAL CHEMISTRY

Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORESM Registry

(2015) Armando Gonzalez-Ruiz et al.   ADVANCES IN THERAPY

Anti-biofilm efficacy of silver nanoparticles against MRSA and MRSE isolated from wounds in a tertiary care hospital

(2015) MA Ansari et al.   Indian Journal of Medical Microbiology

Structure–Activity Relationship for the Oxadiazole Class of Antibiotics

(2015) Edward Spink et al.   JOURNAL OF MEDICINAL CHEMISTRY

Ultrastructural Study on the Antibacterial Activity of Artonin E versus Streptomycin against Staphylococcus aureus Strains

(2015) Asdren Zajmi et al.   PLoS One

In VitroInhibitory and Cytotoxic Activity of MFM 501, a Novel Codonopsinine Derivative, against Methicillin-ResistantStaphylococcus aureusClinical Isolates

(2015) Saiful Azmi Johari et al.   Biomed Research International

In vitro antimicrobial activity of a novel compound, Mul-1867, against clinically important bacteria

(2015) George Tetz et al.   Antimicrobial Resistance and Infection Control

Eugenol: A Phyto-Compound Effective against Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Clinical Strain Biofilms

(2015) Mukesh Kumar Yadav et al.   PLoS One

Discovery of a New Class of Non-β-lactam Inhibitors of Penicillin-Binding Proteins with Gram-Positive Antibacterial Activity

(2014) Peter I. O’Daniel et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Bacteriostatic Antimicrobial Combination: Antagonistic Interaction between Epsilon-Viniferin and Vancomycin against Methicillin-ResistantStaphylococcus aureus

(2014) Dayang Fredalina Basri et al.   Biomed Research International

In VitroandIn VivoActivities of Antibiotic PM181104

(2013) Girish Mahajan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A Current Perspective on Daptomycin for the Clinical Microbiologist

(2013) R. M. Humphries et al.   CLINICAL MICROBIOLOGY REVIEWS

Pharmacokinetics, pharmacodynamics and efficacy of novel FabI inhibitor AFN-1252 against MSSA and MRSA in the murine thigh infection model

(2013) Mary A Banevicius et al.   JOURNAL OF CHEMOTHERAPY

Phenotypic Variants of Staphylococci and Their Underlying Population Distributions Following Exposure to Stress

(2013) Laura A. Onyango et al.   PLoS One

The emerging problem of linezolid-resistant Staphylococcus

(2012) B. Gu et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In Vitro and In Vivo Profiles of ACH-702, an Isothiazoloquinolone, against Bacterial Pathogens

(2011) Michael J. Pucci et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent

(2011) Weon Bin Im et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Manuka honey inhibits cell division in methicillin-resistant Staphylococcus aureus

(2011) R. Jenkins et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections

(2010) Andrew P. Desbois et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS